← All stocks

HAEMONETICS CORP

HAE No buying or selling
CIK 0000313143 #1362 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

16 insiders · 0 transactions
28.5×

Christopher A. Simon holds 28.5 times base salary in stock. $31.38M of shares against $1.10M in salary for 2026.

Salary from the company's own proxy. The shares are what Christopher A. Simon last reported holding, valued at $70.56, the price Common Stock was last bought or sold at on the open market here, on 10 Nov 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Simon, Christopher
President & CEO
444,704
$31.38M
+37.4%
Basil Michelle L
EVP and General Counsel
68,829
$4.86M
+112.9%
DArecca James
EVP, Chief Financial Officer
54,444
$3.84M
+213.9%
Miller Laurie A.
SVP, Human Resources
40,987
$2.89M
+128.3%
Galvin Roy
EVP, Chief Commercial Officer
39,882
$2.81M
+451.2%
Chan Frank
EVP, Chief Operating Officer
32,936
$2.32M
+12,666%
ABERNATHY ROBERT E
Director
27,519
$1.94M
+23.5%
KROLL MARK W
Director
27,295
$1.93M
+32.1%
Zane Ellen M
Director
21,911
$1.55M
+31.4%
Pomeroy Claire
Director
19,410
$1.37M
+36.9%
COYLE MICHAEL J
Director
17,932
$1.27M
+41.2%
Johnson Lloyd Emerson
Director
15,471
$1.09M
+51.1%
Bryant Diane M
Director
9,664
$681.89K
+118.0%
Dockendorff Charles J
Director
7,126
$502.81K
+60.7%
Maunsell Farris Maryanne
VP, Chief Accounting Officer
6,242
$440.44K
+445.6%
Madaus Martin D
Director
2,538
$179.08K

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 27 Oct 2016